Results 11 to 20 of about 24,759 (160)

Luaran Terapi Gancyclovir dan atau Valgancyclovir pada Pasien Infeksi Cytomegalovirus di Instalasi Kesehatan Anak RSUP Dr Sardjito

open access: yesSari Pediatri, 2020
Latar belakang. Infeksi Cytomegalovirus (CMV) merupakan penyebab tersering infeksi kongenital anak di negara berkembang. Infeksi ini dapat menyebabkan tuli sensorineural (SNHL) dan gangguan perkembangan.
Agung Triono   +4 more
doaj   +1 more source

Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis

open access: yesMicrobiology Spectrum, 2022
Cytomegalovirus infection during antiviral prophylaxis occurs in transplant recipients despite individualized regimens based on renal function. Fifty kidney transplant recipients were assessed between 2016 and 2019 for valganciclovir dosing, ganciclovir ...
Diana D. Wong   +10 more
doaj   +1 more source

Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children

open access: yesFrontiers in Pharmacology, 2021
Objective: The present study aims to establish a population pharmacokinetic model of ganciclovir and optimize the dosing regimen in critically ill children suffering from cytomegalovirus related disease.Methods: A total of 104 children were included in ...
SiChan Li   +4 more
doaj   +1 more source

A Case of Severe Ganciclovir-Induced Encephalopathy

open access: yesCase Reports in Neurology, 2013
Background: Ganciclovir, a drug against cytomegalovirus (CMV) infection, is generally well tolerated, but can cause neurotoxicity such as encephalopathy.
Hikaru Sakamoto   +8 more
doaj   +1 more source

Prevention of cytomegalovirus infection after solid organ transplantation: a Bayesian network analysis

open access: yesAnnals of Clinical Microbiology and Antimicrobials, 2020
Background Cytomegalovirus infection is one of the most common complications after solid organ transplantation. There have been several classes of antiviral drugs for the prevention of cytomegalovirus infection, such as acyclovir, valacyclovir ...
Yu Zhang   +4 more
doaj   +1 more source

Repeated intraocular crystallization of ganciclovir in one eye after bilateral intravitreal injections: a case report

open access: yesBMC Ophthalmology, 2018
Background Cytomegalovirus (CMV) retinitis is an opportunistic infection that primarily affects immunocompromised individuals. Intravitreal ganciclovir injection monotherapy or in combination with systemic anti-CMV therapy are effective treatments for ...
Lawrence P. L. Iu   +3 more
doaj   +1 more source

Long Term Therapy of Cytomegalovirus Retinitis with Ganciclovir in a Child with Acquired Immunodeficiency Syndrome

open access: yesCanadian Journal of Infectious Diseases, 1993
Cytomegalovirus retinitis is the most severe ophthalmological complication of patients with acquired immune deficiency syndrome (aids). Ganciclovir must be given continuously to control progression of the disease or relapse typically occurs.
Scott A Halperin, G Robert La Roche
doaj   +1 more source

Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study.

open access: yesPLoS ONE, 2018
PurposeTo investigate the intra-cameral level of ganciclovir following topical application of ganciclovir gel, 0.15% for cytomegalovirus (CMV) anterior segment infection.DesignNon-randomized, prospective, interventional clinical study.MethodsPatients ...
Samanthila Waduthantri   +2 more
doaj   +1 more source

Efficacy and toxicity analysis of ganciclovir in patients with cytomegalovirus lung infection: what is new for target range of therapeutic drug monitoring

open access: yesMicrobiology Spectrum
To investigate the relationship between ganciclovir trough concentration and its clinical efficacy and safety in patients with pulmonary cytomegalovirus (CMV) infection and to evaluate the target value of therapeutic drug monitoring (TDM) for predicting ...
Dongjie Guo   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy